ProfileGDS5678 / 1428251_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 91% 92% 91% 93% 89% 92% 89% 90% 90% 90% 90% 92% 90% 90% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 17.2952691
GSM967853U87-EV human glioblastoma xenograft - Control 27.659692
GSM967854U87-EV human glioblastoma xenograft - Control 37.3666191
GSM967855U87-EV human glioblastoma xenograft - Control 48.1414793
GSM967856U87-EV human glioblastoma xenograft - Control 57.1085389
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 17.4444692
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 26.7831189
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 37.2445990
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 47.2378590
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 17.2472690
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 27.1482990
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 37.6774292
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 47.1876290
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 57.287590